Cargando…
STING and TLR7/8 agonists-based nanovaccines for synergistic antitumor immune activation
Immunostimulatory therapies based on pattern recognition receptors (PRRs) have emerged as an effective approach in the fight against cancer, with the ability to recruit tumor-specific lymphocytes in a low-immunogenicity tumor environment. The agonist cyclic dinucleotides (CDNs) of the stimulator of...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Tsinghua University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014842/ https://www.ncbi.nlm.nih.gov/pubmed/35464625 http://dx.doi.org/10.1007/s12274-022-4282-x |